MINERVA BIOTECHNOLOGIES Corp — Form D

MINERVA BIOTECHNOLOGIES Corp of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-23. The offering totals $25.0M, of which $125K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Kenneth ReedDirectorWaltham, MA
Kenneth ReedRelated PersonWaltham, MA
Kenneth KosikDirectorWaltham, MA
Kenneth KosikRelated PersonWaltham, MA
James R BridgesDirectorWaltham, MA
Robert StaszewskiDirectorWaltham, MA
Robert StaszewskiRelated PersonWaltham, MA
Ronald R AxelrodDirectorWaltham, MA
Joseph Anthony NathanDirectorWaltham, MA
Joseph Anthony NathanRelated PersonWaltham, MA
Lawrence Anthony CoolidgeDirectorWaltham, MA
Kenneth Anthony ReedDirectorWaltham, MA
Cynthia BamdadDirectorWaltham, MA
Cynthia BamdadExecutive OfficerWaltham, MA
Cynthia BamdadPromoterWaltham, MA
Cynthia BamdadRelated PersonWaltham, MA
James F BridgesDirectorWaltham, MA
Normand F SmithDirectorWaltham, MA
Normand S SmithDirectorWaltham, MA
Normand S SmithExecutive OfficerWaltham, MA
James S BridgesDirectorWaltham, MA
James BridgesRelated PersonWaltham, MA
Normand SmithDirectorBoston, MA
Normand F. SmithRelated PersonWaltham, MA
Lawrence CoolidgeRelated PersonWaltham, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2023-12-05D$8.0M$4.5M
2023-01-04D/A$30.0M$328K
2022-01-28D/A$30.0M$24.1M
2019-10-30D$12.0M$1.5M
2019-04-05D$12.0M$4.2M
2018-10-02D$31.2M$29.3M
2014-10-24D$30.0M$2.0M
2010-11-17D$5.9M$4.6M
2010-02-23D$5.0M$1.6M

More